High Cholesterol and Lipid Disorders
What Your Standard Panel Is Missing.
A standard cholesterol panel tells you only part of the story. AvaOne uses advanced lipid testing including ApoB and Lp(a) to identify the cardiovascular risk that conventional screening overlooks.
What "High Cholesterol" Actually Means
High cholesterol is one of the most commonly discussed cardiovascular risk factors and one of the most poorly understood. Most patients leave their annual physical with a single number, total cholesterol, and a directional comment about whether it is “high” or “fine.” That number alone is one of the least useful pieces of cardiovascular risk information available. It can be misleadingly high in patients with low actual cardiovascular risk and misleadingly low in patients whose actual risk is significant.
The cholesterol story is more complex than a single number. Cholesterol is carried through the bloodstream by lipoproteins, each of which behaves differently. LDL cholesterol carries cholesterol to tissues and is associated with plaque formation when elevated. HDL cholesterol carries cholesterol away from tissues and is generally considered protective. Triglycerides are a separate fat measurement linked to metabolic health. Standard cholesterol panels measure all three, but they miss the markers that matter most for individual cardiovascular risk: ApoB and Lp(a).
A meaningful cardiovascular risk assessment moves beyond the basic panel to include advanced lipid testing. The work of preventive cardiology is to look at the full lipid picture, identify the specific risk markers that are elevated, and build a personalized plan that addresses them. The conventional approach of prescribing a statin based on LDL alone misses much of what determines whether a patient actually develops cardiovascular disease.
Why a Standard Cholesterol Panel Is Not Enough
The limitations of standard cholesterol testing are well documented in cardiovascular literature. ApoB, which measures the number of atherogenic particles in the bloodstream, is a more accurate predictor of cardiovascular risk than LDL cholesterol. A patient can have a “normal” LDL cholesterol level while ApoB is elevated, indicating significantly higher cardiovascular risk than the standard panel suggests. The reverse is also true: a patient with mildly elevated LDL but low ApoB may not face the cardiovascular risk a standard panel implies.
Lp(a), or lipoprotein(a), is a separate and equally important marker that is not measured on standard cholesterol panels. Lp(a) is largely inherited and is associated with elevated cardiovascular risk independent of all other risk factors. It does not respond to most cholesterol-lowering medications, which means a patient with elevated Lp(a) requires a different management approach. Roughly one in five adults has elevated Lp(a), and most are unaware because the test is not part of standard cholesterol screening.
The clinical implication is significant. Patients with a family history of heart disease, patients with early-onset cardiovascular events in relatives, and patients with chest pain or cardiovascular symptoms despite normal standard cholesterol panels often have elevated Lp(a) or elevated ApoB that the standard panel did not detect. For these patients, advanced lipid testing is not optional. It is the standard of care recommended by current cardiology guidelines, even though it remains underdelivered in conventional practice because of time and reimbursement constraints.
How AvaOne Approaches Cholesterol and Lipid Disorders
Care for this condition is available at AvaOne location: Edison, NJ, FDA registered
At AvaOne, every preventive cardiology patient receives advanced lipid testing as part of their standard evaluation, not as an optional add-on. This includes ApoB, Lp(a), advanced lipid sub-fractions, and inflammation markers such as high-sensitivity C-reactive protein (hs-CRP).
The goal is to produce a complete lipid picture that reflects the patient’s actual cardiovascular risk, not the limited picture that a basic cholesterol panel provides.
For patients with elevated ApoB but normal LDL, the conversation is different from the conventional “your cholesterol is fine” message. We discuss what ApoB elevation means, what the implications are for cardiovascular risk, and what lifestyle, dietary, and when appropriate, medication strategies can address it. For patients with elevated Lp(a), the conversation centers on the inherited nature of the marker, the limitations of standard cholesterol-lowering medications, and the more aggressive cardiovascular monitoring that elevated Lp(a) warrants.
The AvaOne approach also moves beyond a “statin or no statin” framing. For some patients, statin therapy is clearly indicated and beneficial. For others, particularly those with normal LDL but elevated Lp(a) or elevated ApoB, the management approach involves lifestyle medicine, additional risk modification, and sometimes non-statin therapies. Every plan is built around the individual patient’s complete lipid picture and cardiovascular risk profile, not a one-size-fits-all prescription.
The work is led by Chirag D. Patel, a board-certified interventional cardiologist with the diagnostic depth to interpret advanced lipid testing in clinical context. His training brings a level of cardiovascular risk evaluation expertise that primary care and general cardiology often cannot match.
The Right Program for Patients with High Cholesterol or Lipid Disorders
For most patients with high cholesterol, elevated ApoB or Lp(a), or other lipid disorders, the AvaOne Vitality Program is the right starting point. The Vitality Program is a cardiologist-led preventive longevity membership that includes the comprehensive advanced lipid testing described above, quarterly physician visits, integrated lifestyle coaching, and direct access to your cardiologist between visits.
For patients whose lipid concerns are tightly linked to metabolic health, weight, and lifestyle factors, the Lifestyle and Wellness Coaching Program may be a stronger starting point, with cardiology consultation available as needed. Your physician will recommend the best fit during your Future Self Assessment.
Vitality Program
Cardiologist-Led Preventive Longevity Membership
For adults serious about preventing heart disease and extending healthspan. Membership care led by a board-certified interventional cardiologist with advanced cardiovascular risk assessment, quarterly physician visits, integrated lifestyle coaching, and direct physician messaging.
Available at AvaOne location: Edison, NJ, FDA registered.
Pricing was discussed during your complimentary Discovery Assessment.
What to Expect at Your Future Self Assessment
Every patient begins with a complimentary 15-Minute Discovery Assessment. If you decide to move forward with AvaOne, your next step is a Future Self Assessment — a comprehensive 90-minute physician evaluation.
Detailed Lipid and Cardiovascular History
We review your prior cholesterol testing, any cardiovascular concerns or symptoms, family history of heart disease, current medications including any cholesterol-lowering therapies, and your lifestyle factors that influence lipid metabolism.
Physical Evaluation
A focused cardiovascular physical examination including blood pressure, body composition assessment, and any clinical signs that may inform lipid disorder evaluation.
Advanced Lipid Panel and Risk Testing
We order advanced lipid testing including ApoB, Lp(a), lipid sub-fractions, and inflammation markers, plus any additional cardiovascular risk assessment that your individual profile warrants.
Personalized Lipid Plan
We walk through your complete lipid picture in plain language and build a personalized plan addressing the specific markers that are elevated. The plan may include lifestyle adjustments, nutritional strategy, and when clinically appropriate, medication recommendations coordinated with your primary care physician.
Ready for a Complete Cholesterol and Cardiovascular Risk Picture?
A standard cholesterol panel tells you part of the story. The AvaOne Future Self Assessment gives you the complete picture, with advanced lipid testing and a personalized plan built around your actual cardiovascular risk. Most assessments are scheduled within seven business days.